Eurofins Genomics
John Randolph has a strong background in scientific research and development, with a focus on nucleotide analogs and DNA/RNA synthesis. John has held various positions throughout their career, including Principal Scientist at Eurofins Genomics, Research Associate at McGill University, and Principal Chemist at ELEGEN. Additionally, John spent a significant portion of their career as the Director of Applications Chemistry at Glen Research, where they were responsible for the conceptualization, design, and validation of new nucleotide analogs and labeling reagents, as well as providing technical support to customers and managing quality assurance processes.
John Randolph received their Ph.D. in Chemistry from Carnegie Mellon University, where they studied from 1989 to 1997.
This person is not in any offices
Eurofins Genomics
Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a Life Science Company with laboratories in 61 countries and 61,000 employees. We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression, custom DNA sequencing, oligonucleotides, siRNA and gene synthesis. Our services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide. Imprint: https://www.eurofinsgenomics.eu/imprint/ Privacy Note: https://www.eurofinsgenomics.eu/privacy/